Notice2025-05067

National Center for Advancing Translational Sciences; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 26, 2025

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 57 (Wednesday, March 26, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 57 (Wednesday, March 26, 2025)]
[Notices]
[Page 13755]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-05067]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: April 17, 2025.
    Closed: April 17, 2025, 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Center for Advancing Translational Sciences, 
National Institutes of Health, 9609 Medical Center Drive, Room 
1E454, Rockville, MD 20892 (Virtual).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, 
National Institutes of Health, 9609 Medical Center Drive, Room 
1E454, Rockville, MD 20892, <a href="/cdn-cgi/l/email-protection#b2d3dcdcd39cc0d3dfc1d7cbd7c5dbdcd5f2dcdbda9cd5ddc4"><span class="__cf_email__" data-cfemail="5a3b34343b74283b37293f233f2d33343d1a343332743d352c">[email&#160;protected]</span></a>, (301) 435-
0809.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
<a href="/cdn-cgi/l/email-protection#85cbc6c4d1d6c6eaf0ebe6ece9ccebf5f0f1c5e8e4ece9abebecedabe2eaf3"><span class="__cf_email__" data-cfemail="3e707d7f6a6d7d514b505d575277504e4b4a7e535f57521050575610595148">[email&#160;protected]</span></a>. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: <a href="https://ncats.nih.gov/advisory/council">https://ncats.nih.gov/advisory/council</a>, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-05067 Filed 3-25-25; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on March 26, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.